Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A push for new brain-mapping technology and a ban on some gene patents showcase ongoing advances in biomedical technology.
The FDA is unlikely to rule out personal genetics tests, but it may require that physicians get more involved.
Mapping the genome of a fetus from its mother’s blood could mean less risky screening for prenatal diseases.
A federal investigation finds conflicting test results and false marketing claims.
The FDA plans to overhaul its regulation of the increasingly common diagnostic tests.
RainDance Technologies says its method of amplifying DNA in drops of water will expand clinical genetic testing.
Questions arise over several companies’ plans for over-the-counter genetic tests.